← FDA Drug Approvals (Drugs@FDA)
SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2015-09-29
Drug application
- FDA Application #
ANDA204591- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE
- Generic name
- Sitagliptin Phosphate
- Active ingredients
- SITAGLIPTIN PHOSPHATE; METFORMIN HYDROCHLORIDE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- None (Tentative Approval)
- Sponsor
- TEVA PHARMS USA INC
- First approval
- 2015-09-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown